This is a SOURCES SOUGHT NOTICE only. Responses to this notice will be used for information and planning purposes. No proposals are being requested or accepted with this notice. THIS IS NOT A SOLICITATION FOR PROPOSALS AND NO CONTRACT SHALL BE AWARDED FROM THIS NOTICE. This notice shall not be construed as a solicitation or as an obligation on the part of the Department of Veterans Affairs (VA). Responses to this Sources Sought Notice are not a request to be added to a prospective bidders list or to receive a copy of the solicitation. The VA Gulf Coast Veterans Healthcare System has a requirement for provision of radiopharmaceuticals to its Biloxi, MS and Pensacola, FL locations. This procurement requires daily deliveries to each location as well as additional emergency deliveries when required. The initial period of performance is anticipated to be from April 1, 2013 through September 30, 2013, with four one-year option periods included. This notice is to obtain possible sources that have the capacity and capabilities to include necessary equipment, personnel, licenses, insurance and qualifications to furnish and deliver radiopharmaceuticals to these two facilities. The following information is provided as an estimate only and the estimates are the combined total for both facilities for one year. ITEMS EST QTY UNIT 1. 67 Gallium Citrate a. 6 mCi per each dose 4 DS b. 10 mCi per each dose 2 DS 2. Hippuran, I 131, 250 uCi per each dose for renal scan 1 DS 3. Bone Scans a. 20 mCi per each dose of technetium MDP labeled 327 DS b. 30 mCi each per dose 28 DS 4. Three phase bone 27 mCi per dose of technetium 99m MDP labeled 58 DS 5. Liver/spleen scans, 5 mCi per each dose of technetium 99m Labeled sulfur colloid 3 DS 6. Lung Scans, 4 mCi, per dose of dose of technetium 99m labeled MAA for imaging 23 DS 7. Lung Scans, 60 mCi per each dose of technetium 99m labeled DTPA for imaging 23 DS 8. Gated heart scans a. 20 mCi per each dose of 99m technetium 371 DS b. 30 mCi per each dose 27 DS 9. First Pass heart scans, 27 mCi per each dose of 99m technetium 135 DS 10. Gallbladder, 5mCi per each dose of technetium 99m labeled mebrofenin 38 DS 11. Renal Scans, 5 mCi per each dose of MAG 3 72 DS 12. 201 Thallium Chloride 4 mCi split doses (3mCi/1mCI per each dose 46 DS 13. 99mTC pertechnetate 850 uCi per dose for flood source twice daily 520 DS 14. 99mTC pertechnetate 1 mCi per dose for COR Per month 12 DS 15. 99mTC pertechnetate 250 mCi per dose, dose calibrator linearity per quarter 8 DS 16. 99mTC pertechnetate 5 mCi per dose for dose calibrator linearity per quarter 8 DS 17. 99m technetium labeled WBC CERETEC (pharmacy to tag and supply material) 29 mCi 5 DS 18. I-123 sodium iodide diagnostic capsules for thyroid imaging a. 300 uCI 18 DS b. 100 uCI 18 DS 19. I-131 Sodium Iodide diagnostic capsules for thyroid imaging: 100 uCi 2 DS 20. I-131 Sodium Iodide therapeutic capsules 15 mCi 2 DS 21. I-131 sodium Iodide therapeutic capsules 100 mCi 4 DS 22. 99mTC Neurolite, 25 mCi per dose 2 DS 23. 99mTC Cardiolite (Sestamibi) for heart imaging: a. 10mCi 1075 DS b. 15mCi 16 DS c. 25mCi 7 DS d. 30mCi 1108 DS e. 40mCi 17 DS 24. 99mTC cardiolite (Sestamibi) for parathyroid imaging, 25 mCi per dose 21 DS 25. Reserved 0 DS 26. In-111 Octreoscan For whole body tumor localization 6 mCi per dose 3 DS 27. In-111 labeled leukocyte for osteomyelitis (vendor to tag and supply material) 500 uCi per dose 4 DS 28. 99mTC sulfur colloid for Gastric emptying 1 mCi 50 DS 29. 99mTC technetium for GI bleed 25 mCi 5 DS 30. 99mTC technetium for Hemangioma 25 mCi 5 DS 31. Ultra Tag Kit 10 DS 32. 99mTc technetium ultra fine Filtered for lymphoscintigraphy 1 mCi 2 DS 33. Samorium 153 (Quadramet) 60 mCi 1 DS 34. 99mTC technetium for Salivary gland 10 mCi 2 DS 35. 99mTC technetium for Thyroid Imaging a. 5 mCi 1 DS b. 10 mCi 10 DS 36. 99mTC technetium for ureteral reflux 10 mCi 2 DS Offeror's response to this Notice shall be limited to 5 pages and shall include the following information: " Offeror's company name, DUNS, full address, point of contact, title, phone number, and email address. " Offeror's interest in bidding on the solicitation when it is issued on www.fbo.gov . " Offeror's capability to meet this requirement including any current contracts (Civilian or Government) including manufacturing and delivering radiopharmaceuticals to one or more facilities. Responses must show clear and convincing evidence that your company has the capabilities and qualifications to provide this service to be considered as a source. " Offeror's size of business (small or large) and socioeconomic status (whether Service Disable Veteran Owned Small Business (SDVOSB), Veteran Owned Small Business (VOSB), Hubzone, 8(a), Woman Owned, Small Disadvantaged, etc.). If stating SDVOSB or VOSB status, your company must be verified with the seal/icon or show pending verification in VetBiz Registry (https://www.vip.vetbiz.gov//) to be considered a SDVOSB or VOSB source. " The NAICS code for this procurement is 325412, Pharmaceutical Preparation Manufacturing, and the small business size standard is 750 employees. Responses must be received no later than 3 pm CST, February 8, 2013. Responses may be emailed to [email protected] using Sources Sought Number "VA256-13-R-0368" in the subject line. Facsimile or Telephonic responses will not be accepted. Simply responding as an "interested party" in www.fbo.gov doesn't constitute your company as a source. Offerors must provide the above requested information. After a review of the responses to this Sources Sought Notice, a solicitation will be posted on the FBO website in the next 30 -45 days. Responses to this Sources Sought Notice are not and will not be considered adequate responses to the solicitation announcement. All interested offerors will have to respond to the solicitation announcement in addition to responding to this Sources Sought Notice. All interested parties are reminded to be registered with the System for Award Management (SAM) at https://www.sam.gov in order to be eligible for award of Government contracts.

Bid Protests Not Available